tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Esperion’s US Market Stagnation Overshadows Japanese Approval, Justifying Sell Rating
PremiumRatingsEsperion’s US Market Stagnation Overshadows Japanese Approval, Justifying Sell Rating
14d ago
Esperion’s Strategic Milestone: Nexletol Approval in Japan Boosts Financial Outlook with $120 Million Potential
Premium
Ratings
Esperion’s Strategic Milestone: Nexletol Approval in Japan Boosts Financial Outlook with $120 Million Potential
17d ago
Esperion’s Strategic Advancements: Regulatory Approval and Market Expansion Boost
Premium
Ratings
Esperion’s Strategic Advancements: Regulatory Approval and Market Expansion Boost
17d ago
Esperion Therapeutics’ Earnings Call Highlights Growth
PremiumCompany AnnouncementsEsperion Therapeutics’ Earnings Call Highlights Growth
2M ago
Esperion’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating
Premium
Ratings
Esperion’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating
2M ago
Esperion reports Q2 EPS 2c, consensus (16c)
Premium
The Fly
Esperion reports Q2 EPS 2c, consensus (16c)
2M ago
Esperion Expands Board with New Appointment
PremiumCompany AnnouncementsEsperion Expands Board with New Appointment
3M ago
Esperion appoints Craig Thompson to board of directors
Premium
The Fly
Esperion appoints Craig Thompson to board of directors
3M ago
Esperion’s Strategic Growth and Global Expansion Drive Buy Rating
Premium
Ratings
Esperion’s Strategic Growth and Global Expansion Drive Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100